Media Summary: Hepatitis C Antiviral Resistance Revealed Dr. Douglas Dieterich is a man on a mission to cure a disease he was diagnosed with himself: This week, Nimesh Nagarsheth, MD, an associate professor of obstetrics, gynecology, and reproductive

Hepatitis C Antiviral Resistance Revealed By Mount Sinai Scientists - Detailed Analysis & Overview

Hepatitis C Antiviral Resistance Revealed Dr. Douglas Dieterich is a man on a mission to cure a disease he was diagnosed with himself: This week, Nimesh Nagarsheth, MD, an associate professor of obstetrics, gynecology, and reproductive Our ARUP Institute for Learning Spotlight Series is designed to provide brief educational overviews highlighting test utilization ... Dr. Douglas Dieterich, Professor of Medicine in the Division of Liver Diseases at the Icahn School of Medicine at Dr. Stuart Ray discusses which genotypes may be more appropriate for pretreatment

Drs. Drenth and Berden discuss their manuscript "Identification of the Best Direct-Acting New insights into human biology and the ability to manipulate molecules both large and small are rapidly accelerating medical ... Dr. Douglas Dieterich discusses the treatment options that are available for In partnership with the Centers for Disease Control and Prevention (CDC), ALF hosted a webinar for our robust network of liver ... HIV grand rounds held on April 24, 2017 in

Photo Gallery

Hepatitis C Antiviral Resistance Revealed by Mount Sinai Scientists
The Leadership to a Cure: Hepatitis C
Mount Sinai Spotlight: Cervical Cancer Awareness & Hepatitis C
Secrets of Hepatitis C Virus Revealed
Spotlight on Testing: Hepatitis C Virus NS5A Drug Resistance by Sequencing
The Patient-Doctor Journey: Hep C Cure
The Mount Sinai Liver Disease and Action Program Team
Models of Hepatitis C Treatment for Persons with Substance Use Disorders
Pretreatment resistance testing for HCV
Mount Sinai research reveals effects of "long COVID"
Identification of the Best Direct-Acting Antiviral Regimen for Patients With Hepatitis C Virus...
Transplantation of HCV-Positive Organs in the Era of DAA
Sponsored
Sponsored
View Detailed Profile
Hepatitis C Antiviral Resistance Revealed by Mount Sinai Scientists

Hepatitis C Antiviral Resistance Revealed by Mount Sinai Scientists

Hepatitis C Antiviral Resistance Revealed

The Leadership to a Cure: Hepatitis C

The Leadership to a Cure: Hepatitis C

Dr. Douglas Dieterich is a man on a mission to cure a disease he was diagnosed with himself:

Sponsored
Mount Sinai Spotlight: Cervical Cancer Awareness & Hepatitis C

Mount Sinai Spotlight: Cervical Cancer Awareness & Hepatitis C

This week, Nimesh Nagarsheth, MD, an associate professor of obstetrics, gynecology, and reproductive

Secrets of Hepatitis C Virus Revealed

Secrets of Hepatitis C Virus Revealed

Scientists

Spotlight on Testing: Hepatitis C Virus NS5A Drug Resistance by Sequencing

Spotlight on Testing: Hepatitis C Virus NS5A Drug Resistance by Sequencing

Our ARUP Institute for Learning Spotlight Series is designed to provide brief educational overviews highlighting test utilization ...

Sponsored
The Patient-Doctor Journey: Hep C Cure

The Patient-Doctor Journey: Hep C Cure

Dr. Douglas Dieterich, Professor of Medicine in the Division of Liver Diseases at the Icahn School of Medicine at

The Mount Sinai Liver Disease and Action Program Team

The Mount Sinai Liver Disease and Action Program Team

The

Models of Hepatitis C Treatment for Persons with Substance Use Disorders

Models of Hepatitis C Treatment for Persons with Substance Use Disorders

A

Pretreatment resistance testing for HCV

Pretreatment resistance testing for HCV

Dr. Stuart Ray discusses which genotypes may be more appropriate for pretreatment

Mount Sinai research reveals effects of "long COVID"

Mount Sinai research reveals effects of "long COVID"

New research from

Identification of the Best Direct-Acting Antiviral Regimen for Patients With Hepatitis C Virus...

Identification of the Best Direct-Acting Antiviral Regimen for Patients With Hepatitis C Virus...

Drs. Drenth and Berden discuss their manuscript "Identification of the Best Direct-Acting

Transplantation of HCV-Positive Organs in the Era of DAA

Transplantation of HCV-Positive Organs in the Era of DAA

A

Mount Sinai Health System Presents: The Quest for Breakthrough Therapies

Mount Sinai Health System Presents: The Quest for Breakthrough Therapies

New insights into human biology and the ability to manipulate molecules both large and small are rapidly accelerating medical ...

Hepatitis C

Hepatitis C

Farah from

Is HCV drug resistance an issue? | Jürgen Rockstroh, MD

Is HCV drug resistance an issue? | Jürgen Rockstroh, MD

Asian Conference on

What Treatment Options Are Available for Hepatitis?

What Treatment Options Are Available for Hepatitis?

Dr. Douglas Dieterich discusses the treatment options that are available for

Hepatitis C Virus: Barriers to Treatment and Community-focused Primary Care

Hepatitis C Virus: Barriers to Treatment and Community-focused Primary Care

In partnership with the Centers for Disease Control and Prevention (CDC), ALF hosted a webinar for our robust network of liver ...

HIV/HCV Co-infection

HIV/HCV Co-infection

HIV grand rounds held on April 24, 2017 in

Debate: Testing for Hepatitis C Resistance: Con-Standpoint | Jean-Michel Pawlotsky, MD, PhD

Debate: Testing for Hepatitis C Resistance: Con-Standpoint | Jean-Michel Pawlotsky, MD, PhD

Lecture: Debate: Testing for

Researchers at Mount Sinai Identify New Gene That Drives Colon Cancer

Researchers at Mount Sinai Identify New Gene That Drives Colon Cancer

Researchers